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Abstract
ATP-dependent Mur ligases (Mur synthetases) play essential roles in the biosynthesis of cell wall peptidoglycan (PG) as they
catalyze the ligation of key amino acid residues to the stem peptide at the expense of ATP hydrolysis, thus representing
potential targets for antibacterial drug discovery. In this study we characterized the division/cell wall (dcw) operon and
identified a promoter driving the co-transcription of mur synthetases along with key cell division genes such as ftsQ and
ftsW. Furthermore, we have extended our previous investigations of MurE to MurC, MurD and MurF synthetases from
Mycobacterium tuberculosis. Functional analyses of the pure recombinant enzymes revealed that the presence of divalent
cations is an absolute requirement for their activities. We also observed that higher concentrations of ATP and UDP-sugar
substrates were inhibitory for the activities of all Mur synthetases suggesting stringent control of the cytoplasmic steps of
the peptidoglycan biosynthetic pathway. In line with the previous findings on the regulation of mycobacterial MurD and
corynebacterial MurC synthetases via phosphorylation, we found that all of the Mur synthetases interacted with the Ser/Thr
protein kinases, PknA and PknB. In addition, we critically analyzed the interaction network of all of the Mur synthetases with
proteins involved in cell division and cell wall PG biosynthesis to re-evaluate the importance of these key enzymes as novel
therapeutic targets in anti-tubercular drug discovery.
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Introduction
Tuberculosis (TB) is a one of the leading causes of human
mortality from infectious diseases with an estimated 1.4 million
deaths globally in 2011 [1]. Control of TB has become much
harder with the recent emergence of extensively-drug resistant TB
(XDR-TB) strains, as there is virtually no effective drug available
for their treatment [2]. Therefore new drugs with novel
mechanisms of action are urgently required to tackle the spread
of drug-resistant TB strains.
Mycobacterium tuberculosis, the causative pathogen of TB, is
extremely tolerant to chemical agents and this feature is attributed
to its remarkably impermeable cell wall, which consists of
a covalently linked mycolyl-arabinogalactan-peptidoglycan
(mAGP) complex. The cell wall peptidoglycan (PG), which is
unique to bacteria, provides a rigid support that gives the cell its
shape and maintains its turgidity [3]. PG biosynthesis is the target
of several clinically useful antibiotics (cycloserine, bacitracin,
vancomycin and b-lactams) and its regulation is thought to be
correlated with critical biological processes such as bacterial cell
elongation and division, thus validating the pathway as a pro-
spective source of vulnerable targets for antibacterial drug
discovery [4]. To date not a single clinically available drug has
been reported to target ATP-dependent Mur ligases (Mur
synthetases), which are key enzymes of the PG biosynthetic
pathway. Our findings on the inhibition of MurE synthetase in M.
tuberculosis have highlighted this group of enzymes as potential anti-
mycobacterial targets [5,6,7].
During PG biosynthesis, the soluble muropeptide precursors are
synthesized in the mycobacterial cytoplasm and are then
translocated across the cytoplasmic membrane to the periplasmic
space where they undergo transglycosylation and transpeptidation
reactions carried out by the penicillin binding proteins (PBPs) [8],
to form mature PG. Mur synthetases are key central enzymes in
the cytoplasmic steps of PG biosynthesis. MurC initiates the
formation of the stem peptide by adding L-alanine (L-Ala) to the
carboxyl group of uridine-diphospho-N-acetyl-muramic acid
(UDP-MurNAc), while MurD, MurE and MurF sequentially add
D-glutamate (D-Glu), meso-diaminopimelate (m-DAP) and D-
alanine-D-alanine (D-Ala-D-Ala) forming the stem pentapeptide
UDP-MurNAc-L-Ala-c-D-Glu-m-DAP-D-Ala-D-Ala [9]. The
presence of m-DAP and D-Ala-D-Ala residues in the soluble PG
precursor is essential for the later crosslinking of adjacent
muropeptide residues in the final steps of PG biosynthesis [3].
Mur synthetases have been characterized in several micro-
organisms [10,11,12]; however knowledge of the structure,
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function and regulation of these enzymes is still fragmented in M.
tuberculosis. Mahapatra et al (2000) reported that MurC was able to
incorporate glycine (Gly) and L-Ala to UDP-MurNAc in both M.
tuberculosis and M. leprae [13]. Our investigation of the structural
and functional characterization of MurE from M. tuberculosis
[14,15] revealed that MurE was only active in the presence of its
specific natural substrates: uridine-diphospho-N-acetylmuramoyl-
L-alanine-D-glutamate (UDP-MurNAc-L-Ala-D-Glu), m-DAP
and ATP. In this study, we comprehensively examine and
compare the activity of all Mur synthetases in M. tuberculosis with
respect to their natural substrates.
All of the four genes for the M. tuberculosis Mur synthetases are
positioned close to each other in the division/cell wall (dcw) cluster,
which also contains key cell division genes. Since cell elongation
and septum formation during cell division involves recruitment of
both cell wall PG biosynthetic and cell division proteins [3], their
co-transcription may be important for the proliferation of
mycobacteria. In this study we report the analysis of the dcw
operon and demonstrate for the first time the promoter driving the
co-transcription of mur synthetases and the adjacent cell division
genes. Moreover, growing evidence that these groups of proteins
interact to form a complex during cell division, further prompted
us to investigate the network of interaction of the proteins of the
dcw operon.
In order to understand the protein-protein interaction network
of MurC, D, E, and F synthetases, we also analyzed other key
protein partners which are involved in their regulation and/or PG
biogenesis. These included the serine-/threonine protein kinases
(STPKs), PknA and PknB that have been reported to regulate cell
wall biosynthesis, cell division, pathogenicity and survival during
various stress conditions through phosphorylation/dephosphory-
lation of their target protein substrates [16]. We also investigated
proteins involved in the production of the amino acid substrates
for Mur synthetases, such as glutamate racemase (MurI),
diaminopimelate epimerase (DapF) and D-alanine:D-alanine
ligase (DdlA) [17,18,19]. Furthermore, as the amino sugar units
of mycobacterial muropeptides have uniquely been found to be
both N-acetylated and N-glycolylated [20], it was therefore
intriguing to determine at which step during the PG biosynthesis
the NamH protein [21] caused this modification. Combining basic
bioinformatic data analysis with our in vivo protein-protein
interaction experimental results, we attempted to uncover an
endogenous interaction network for these proteins.
Materials and Methods
Bacterial strains, plasmids and chemicals
Escherichia coli DH5a (Promega) was used for cloning, and E. coli
BL21(DE3)/pLysS and Pseudomonas putida KT2442 for overexpres-
sing M. tuberculosis Mur synthetases. pET28b(+), pET43.1b(+)
(Novagen) and pVLT31 were used for the overexpression of
mycobacterial proteins in E. coli and P. putida, respectively.
Mycobacterium smegmatis mc2155 was used as host, while the
pUAB100 and pUAB200 plasmids were used as the vectors for
in vivo protein-protein interaction studies. All restriction endonu-
cleases were purchased from New England Biolabs. All other
media and chemicals were purchased from Sigma-Aldrich unless
mentioned otherwise.
Cloning of M. tuberculosis genes
The murC (Rv2152c) and murF (Rv2157c) genes were amplified
from M. tuberculosis H37Rv genomic DNA using Phusion hot start
DNA polymerase and primers listed in table S1, and cloned into
pET28(b)+ vector at NdeI/BamHI sites to obtain pSBC2 and
pSBC4 respectively. pVLT31, derived from pMMB207, does not
encode for a fusion-tag [22]; hence pSBC1 [15], pSBC2 and
pSBC4 were digested with XbaI/HindIII to give ,2.0 kb
fragments containing the ribosome binding site (RBS), His-tag,
a thrombin cleavage site and the genes of interest, which were then
sub-cloned into pVLT31 at the same sites to obtain p31E, p31C
and p31F respectively.M. tuberculosis murD (Rv2155c) was cloned in
frame with NusA using BamHI/HindIII sites in the pET43.1(b)+
vector, which also contains a His-tag, and thrombin and
enterokinase cleavage sites in the linker region (Table S2), to
obtain p43D. The clones were selected in E. coli DH5a, confirmed
by sequencing and then used to transform E. coli BL21(DE3)/
pLysS and electro-competent P. putida KT2442 in the presence of
kanamycin (50 mg/mL) and chloramphenicol (34 mg/mL) for
pSBC1, pSBC2 and pSBC4, ampicillin (100 mg/mL) and chlor-
amphenicol (34 mg/mL) for p43D and tetracycline (12.5 mg/mL)
and rifampicin (10 mg/mL) for p31C, p31E and p31F respectively.
To construct bait clones for protein interaction studies, murC,
murD, murE (Rv2158c), murF and nat (Rv3566) were PCR amplified
from M. tuberculosis H37Rv genomic DNA using the primers listed
in table S1 and cloned into integrating vector pUAB200 at MfeI/
ClaI sites, except for MurE where the MfeI site was present within
the gene so it was replaced with EcoRI, to obtain murC200,
murD200, murE200 murF200 and nat200. Similarly, for prey
constructs, pknA (Rv0015c), pknB (Rv0014c), murI (Rv1338), dapF
(Rv2726c), ddlA (Rv2981c) namH (Rv3818), Rv2160c, ftsW
(Rv2154c), ftsQ (Rv2151c), ftsZ (Rv2150c), sepF (Rv2147c) and
wag31 (Rv2145c) genes were PCR amplified and ligated into the
episomal vector pUAB100 (restriction enzyme sites are underlined
in the primers as shown in table S1) to produce pknA100,
pknB100, murI100, dapF100, ddlA100, namH100, Rv2160-100,
ftsW100, ftsQ100, ftsZ100, sepF100, and wag100 respectively.
The pUAB200 and pUAB100 constructs were amplified in E. coli
DH5a and then selected in the presence of kanamycin (50 mg/mL)
and hygromycin (150 mg/mL) respectively. All clones were
confirmed by DNA sequencing.
Over-expression and purification of M. tuberculosis Mur
synthetases
One litre Luria Bertani (LB) P. putida cultures, supplemented
with tetracycline and rifampicin, were grown at 30uC, induced
with 1 mM IPTG at OD 0.8 and incubated for a further 16 h for
expression of the recombinant protein. For MurD, E. coli cultures
were supplemented with ampicillin and chloramphenicol and
grown at 37uC, induced with 0.5 mM IPTG at OD 0.6 and
incubated for 16 h at 18uC. The cells were harvested and lysed by
sonication (10 mm amplitude, 5630 s pulse with 1 min cooling
interval) in chilled lysis buffer [25 mM Tris. HCl, 300 mM NaCl,
10% glycerol and 5 mM b-mercaptoethanol (pH 8.0)]. Expression
of recombinant proteins was confirmed by western blot using
alkaline phosphatase conjugated His-tag antibodies. The cytoplas-
mic fraction was separated by centrifugation at 50,0006g for 1 h
at 4uC. For purification, the cytoplasmic fraction containing the
recombinant protein was applied to a pre-equilibrated Ni2+-NTA
column, followed by washing with lysis buffer containing 25 mM
imidazole and eluted with 200 mM imidazole. The peak fractions
were analyzed by 12.5% SDS-PAGE. The pure fractions were
pooled, concentrated by ultrafiltration (10 kDa cut-off) at 4uC and
cleaved with thrombin at a concentration of 2 units per mg of
protein overnight at 4uC. The concentrated proteins were further
purified by size exclusion chromatography using a Sephacryl 200
column (GE Healthcare) attached to an Akta chromatographic
system (Amersham Biosciences) in 25 mM Tris-HCl, 100 mM
NaCl and 1 mM b-mercaptoethanol buffer (pH 8.0). For MurD,
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ion-exchange chromatography was carried out using a HiTrapTM
IEX XL column (GE Healthcare) to further purify the protein.
The concentration of purified proteins was estimated using
a Nanodrop 1000 spectrophotometer (Thermo Fisher Scientific)
and proteins were stored in 10% glycerol at 280uC with minimal
loss of activity.
Functional assay for M. tuberculosis Mur synthetases
Enzyme activities were assayed by measuring the release of
orthophosphate following enzymatic ATP hydrolysis using the Pi
ColorLock Gold kit (Innova Biosciences) as reported earlier [15].
The optimum buffer and pH was determined using Tris–HCl
(between pH 7.0–9.0), Bis-tris–propane–HCl (pH 7.0–9.0),
HEPES-NaOH (pH 7.0–8.0) and Bis-tris-HCl (pH 7.0–8.0). The
thermal stabilities of the purified enzymes were determined by
measuring enzyme activities over a linear range of temperatures
from 10 to 70uC. The optimized assay was performed in a final
volume of 50 mL using 100–200 ng of enzyme in the presence of
50 mM Bis-tris buffer (pH 8.5), 5 mMMgCl2, 1 mM ATP, 1 mM
of amino acids L-Ala, D-Glu or D-Ala-D-Ala and 0.1 mM of the
relevant UDP-MurNAc substrates at 37uC for 30 min. The
absorbance was measured at 635 nm using a FLUOstar Omega
plate reader (BMG Labtech). To control for any non-enzymatic
hydrolysis of ATP, the background absorbance of the reaction
mixture without enzyme was measured and subtracted from the
absorbance values with enzyme. Each reaction was performed in
triplicate and the standard deviation of the mean was calculated
and is shown as error bars. The steady-state kinetic parameters
were determined for each of the three substrates, and their
Michaelis constant (KM) and maximal reaction velocity (Vmax) were
determined by non-linear regression analysis based on the
Michaelis-Menten equation. The substrate specificity experiments
were conducted by assessing the ATPase activity in the presence of
1.5 mM concentration of different amino acids, 1 mM concen-
tration of different nucleotides and 0.5 mM concentration of
different UDP-sugars.
HPLC analysis
The ligase activity was evaluated on an Agilent 1100 Series
HPLC instrument (Agilent Technologies, Palo Alto, CA) at a flow
rate of 0.5 mL/min with absorbance continually measured at 220
and 268 nm as reported earlier [6]. The stationary phase used for
the separation was an octadecylsilane (RP-18) Jones chromatog-
raphy column (4.6 mm6250 mm65 mm). Elution was carried out
isocratically with a buffer of 50 mM ammonium formate at
pH 4.0. A calibration curve was constructed for UDP-MurNAc (rt
= 7.5 min) and UDP-MurNAc-L-Ala (rt = 11.6 min), resulting in
linear responses at 268 nm with correlation factors (R2) of 0.99835
and 0.99895, respectively. The assay conditions were exactly the
same as in the colorimetric assay. After incubation for 30 min, the
reaction was stopped by heating for 10 minutes at 100uC. The
resulting sample was centrifuged and transferred to HPLC vials
with glass inserts. The amount of product formed was calculated
from the values of the area under the peaks and quantified with
the calibration curve. The peaks were further analysed by liquid
chromatography – mass spectrometry (LC-MS) performed on
a Finnigan LCQ ion trap mass spectrometer (ThermoFinnigan,
San Jose, CA) coupled to an Alliance Waters 2695 HPLC
Separations Module (Milford, MA, USA).
dcw operon analysis
Total RNA was extracted from Mycobacterium bovis BCG (three
biological replicates in duplicates) that were grown to an OD600 of
0.4–0.6 using the GTC method [23]. cDNA was synthesised using
the Super Script Reverse Transcriptase III kit (Invitrogen)
according to the manufacturer’s instructions. Mock cDNA samples
were also prepared where Super Script III Reverse Transcriptase
was replaced by water and used as a negative control to detect
genomic DNA (gDNA) contamination. The overlapping regions of
the genes in the dcw cluster were amplified from the cDNA using
Taq DNA polymerase (NEB) and primers outlined in table S3. A
positive control using genomic DNA extracted from M. bovis BCG
was also included. The PCR products were analysed in a 1.2%
agarose gel following standard procedures.
To screen for the presence of a promoter driving the dcw operon
in M tuberculosis, the regions upstream of the putative operon were
investigated. These regions were between ORFs Rv2159c-Rv2158c
(murE) (P1) and Rv2162c (PE_PGRS38)-Rv2161c (P2). The P1 and
P2 regions were cloned into the BamHI site of the transcriptional-
translational vector pYUB76 using primers as shown in table S1,
driving expression of a downstream lacZ gene, and screened for
blue colonies of M. smegmatis mc2155 on kanamycin (50 mg/mL)
and X-gal (50 mg/mL) plates. The confirmation of promoter
activity was done by measuring b-galactosidase activity in the
presence of 2-nitrophenyl-b-D-galactopyranoside (ONPG) as
a substrate [24].
Protein-protein interaction assay
M. smegmatis was co-transformed with each pair of bait (murC/
D/E/F/nat) and prey (pknA, pknB, murI, dapF, ddlA, namH, Rv2160c,
ftsW, ftsQ, ftsZ, sepF, wag31 as well as murC/D/E/F) constructs. The
double transformants were selected on Middlebrook 7H11
medium (MB7H11) supplemented with 0.2% tween-80, 0.5%
glycerol, 0.5% glucose, kanamycin (25 mg/mL) and hygromycin
(50 mg/mL).
To perform the interaction assay, the same numbers of equal
sized colonies were suspended in PBS followed by streaking of cells
onto MB7H11 media containing kanamycin, hygromycin and
trimethoprim (TMP) (12.5 mg/mL). Plates without TMP were the
growth control. The plates were incubated at 37uC for 7 days and
growth was observed. All bait and prey constructs alone had
minimum bactericidal concentrations of less than 6.25 mg/mL for
TMP. The pUAB200::pUAB100 (both consisting leucine-zipper
GNC4) and inhA200::fabD100 co-transformant, reported earlier
as interacting partners [25] were used as positive controls, while
unrelated protein AccD6 (Rv2247) in combination with MurC
(murC200::accD6-100), arylamine N-acetyltransferase/Nat
(Rv3566) with cell division proteins (nat200::ftsW/ftsQ/ftsZ/
sepF/wag31-100) and MurC with empty vector (murC200::-
pUAB100) were taken as negative controls. All interactions were
repeated twice for confirmation. For quantitative analysis, two-fold
serial dilutions of TMP were made in a 96-well plate using
Middlebrook 7H9 medium (MB7H9) with tween-80 and glycerol,
and then an equal number of co-transformants (,106 colony-
forming units) were added to each well. The plates were incubated
for 16 h at 37uC after which 30 mL of 0.01% (w/v) of freshly
prepared resazurin was added to each well. Samples were assayed
in triplicate and after 16 h of incubation at 37uC, a change in color
intensity from blue to pink was observed, and fluorescence was
measured at lexc560/lemi590 nm using a fluorimeter (FLUOstar
Omega plate reader, BMG Labtech).
Results
Mur synthetases purified in active and appropriately
folded form
Achieving sufficient quantities of pure MurC and MurF proteins
using expression in E. coli presented a challenge, as the native E.
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coli proteins, SlyD and ArnA which were identified by protein
sequencing, co-eluted with the Mur synthetases. Switching to P.
putida strain KT2442 [22], achieved elevated levels of significantly
purer hexa His-tagged MurC and MurF recombinant proteins
expressed at 30uC compared to E. coli BL21(DE3)/pLysS
expressed protein at either 18uC or 30uC (data not shown). Using
P. putida also improved the purity of the MurE protein compared
to that obtained with E. coli previously [15]. The presence of a His-
tag in the pVLT31 plasmid in frame with the proteins of interest
allowed western blot analysis and purification using Ni2+-NTA to
get homogenous enzymes as visualised by SDS-PAGE (Fig. 1A).
The purity obtained for each protein using P. putida as a host for
over-expression was considerably higher (,95%) in comparison to
that achieved with E. coli (,85%). MurD, however posed a further
solubility problem using the above strategies, but was successfully
over-expressed and purified as a fusion protein with E. coli NusA,
known for its ability to confer solubility to insoluble proteins [26].
MurC (51.5 KDa), MurD (51.0 KDa), MurE (55.3 KDa) and
MurF (51.6 KDa) (table S2) were purified to achieve yields of
12 mg, 4 mg, 12 mg and 8 mg per liter of culture respectively.
They ran as monomeric proteins on gel filtration chromatography.
The colorimetric activity assay [15] and CD analysis (data not
shown) confirmed that all Mur synthetases were active and
correctly folded. The specific activities of MurC, MurD, MurE
and MurF were estimated to be 1.2, 0.8, 1.3 and 0.9 mmoles of
inorganic phosphate formed by enzyme catalysis per min per mg
of protein (Fig. 1B).
Temperature and pH affect enzyme activity and stability
The ATPase assay for Mur synthases was conducted in a 96-
well half-area plate in 50 mL reaction volumes as reported earlier
for MurE [15]. After testing several concentrations of the proteins
(10–500 ng), the assay was carried out with a final concentration of
100 ng of MurC and MurF, and 150 ng of MurD. The stability of
all proteins was notably affected by temperature and ionic
strength. The effect of temperature was studied between 10 and
70uC and stable activity was observed below 40uC. When the
proteins were incubated at higher temperature, the activity of all
three proteins, especially MurC diminished across a temperature
range of 45 to 70uC (Fig. S1 [Ai]). The optimum temperatures for
activity were between 35 and 40uC for all four proteins. Moreover,
almost 50% loss of activity was observed for the proteins within
a week when stored at room temperature (25uC), with MurC
showing a much steeper decrease in activity than MurD and MurF
(Fig. S1 [Aii]). Optimum activity was achieved using Tris-HCl
buffer at pH 8.0 for MurC and MurF, and Bis-tris propane at
pH 8.5 for MurD, however, as the difference was not large, Bis-tris
propane was used for assaying all three proteins (Fig. S1 [B]). The
activity of the proteins in HEPES and Bis-tris buffers was
considerably low at these pHs (,50%).
Substrate specificity and kinetic parameters of MurC, D
and F
We carried out characterisation of MurC, D and F to
complement our previously published data on MurE [14,15].
The specificities of MurC, MurD and MurF for their respective
substrates were investigated. Among the nucleotides and UDP
sugars tested, only ATP and UDP-MurNAc (for MurC)/UDP-
MurNAc-L-Ala (for MurD)/UDP-MurNAc-L-Ala-c-D-Glu-m-
DAP (for MurF) exhibited activity (Fig. 2A and 2C). Furthermore,
MurD and MurF showed activity only with D-Glu and D-Ala-D-
Ala respectively among the amino acids examined. However, in
the case of MurC, the activity was observed with L-Ala as well as
Gly and L-Ser (Fig. 2B). This result was confirmed by HPLC
which showed the presence of new peak different to that of the L-
Ala-ligated product at a retention time (rt) of 6.8 min for L-Ser,
whereas the peak for the Gly-ligated product co-eluted with the
UDP-MurNAc substrate at 7.3 min. Further analysis by LC-MS
revealed the presence of deprotonated anions in negative-mode
MS for the product peaks at the expected mass/charge ratio (m/z)
of 749.0, for UDP-MurNAc-L-Ala, 764.9 m/z for UDP-MurNAc-
L-Ser and 735.0 m/z for UDP-MurNAc-Gly (Fig. S2). The KM
values obtained for L-Ala, L-Ser and Gly were 43.0, 99.7 and
146.6 mM respectively, being higher than those reported earlier
for L-Ala and Gly [13]. This difference could be attributed to the
different methods used to assay the activity of MurC.
Several monovalent and divalent cations were also tested for
their effect on MurC, MurD and MurF activities, as in the absence
of added metal ions there was very little detectable product. The
L-Ala, D-Glu, m-DAP and D-Ala-D-Ala adding activity of MurC,
MurD, MurE [15] and MurF respectively, was found to be highly
dependent on the Mg2+ concentrations as has also been seen with
other microorganisms [27,28]. MgCl2 exhibited maximum activ-
ity, followed by MnCl2 which in the case of MurD was comparable
to Mg2+. Other divalent cations that could be substituted for Mg2+
or Mn2+ were Co2+ (for MurC and MurD) and Zn2+ (for MurD),
Figure 1. Analysis of purified recombinant M. tuberculosis Mur
synthetases. (A) SDS-PAGE analysis of MurC (lane 1), MurD (lane 2),
MurE (lane 3) and MurF (lane 4) with protein molecular weight markers
(lane 5) and (B) specific activity of each protein. Error bar at 1 SD based
on assays conducted in triplicate for each protein.
doi:10.1371/journal.pone.0060143.g001
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although the activities were considerably lower than those
observed for Mg2+ or Mn2+ (Fig. 2D). Monovalent ions K+ and
NH4
+ were slightly better than some divalent ions at replacing
Mg2+. Monovalent ions were previously found to stimulate the
activity of MurD in E. coli and Haemophilus influenzae [28], although
this may have been enhancing the rate in the presence of Mg2+.
MgCl2 showed the highest activity at 5 mM for all three proteins,
followed by MnCl2 at 10 mM for MurC and 5 mM for MurD and
MurF. The activity of these proteins was reduced by .80% when
using an increased concentration (.20 mM) of MgCl2 or MnCl2
(data not shown).
Kinetic experiments showed that the optimal concentration of
ATP and UDP sugar was 1000 mM and 200 mM respectively for
steady state kinetics at 37uC (Fig. 3). Using twice these
concentrations reduced the activity of the enzymes to around
80% of the maximal activity. This finding is in agreement with
the earlier published data for E. coli MurD [28] and Pseudomonas
aeruginosa MurE [29]. The Michaelis constant (KM) values
obtained for M. tuberculosis MurC (Table 1), were found to be
lower for UDP-MurNAc and ATP and similar for L-Ala in
comparison to the published values for E. coli MurC [30]. MurD
on the other hand exhibited higher KM values for UDP-
MurNAc-L-Ala whereas ATP and D-Glu values were compara-
ble to those obtained for E. coli MurD [28]. However, kinetic
analysis of M. tuberculosis MurD by Barreteau et al [31] showed
higher KM values, which might be attributed to the difference in
assay methods used for analysis. Similarly the KM values for ATP
and UDP-MurNAc-L-Ala-c-D-Glu-m-DAP were obtained for
MurF, but were much lower than those published for either
Staphylococcus aureus or E. coli MurF [11,32]. Furthermore, all
three synthetases showed at least a 2-fold higher specificity (kcat/
KM) towards their sugar substrates than their ATP or amino acid
substrates, which is expected for bigger substrates compared to
small substrates, as more interactions (electrostatic, hydrogen
bonds, van der Waals) are possible throughout the length of the
substrate.
Characterisation of dcw operon
The entire reverse direction (27.9 kb) region containing the
dcw gene cluster in M. tuberculosis was studied and the overlaps or
gaps were identified between each open reading frame. Total
RNA was extracted and cDNA prepared from M. bovis BCG as
the dcw region is identical to that in M. tuberculosis in the
intergenic regions and shows only five single nucleotide changes
in the coding sequences. To confirm the span of the dcw operon
(Fig. 4A), reverse transcriptase PCR (RT-PCR) was carried out
from PE_PGRS38 to ftsZ genes using primers designed to overlap
adjacent genes and amplify intergenic regions. No amplification
was observed between the PE_PGRS38-Rv2161c, Rv2159c-murE
and ftsQ-ftsZ regions (Fig. 4B). This indicated that the Rv2161c-
Rv2160c-Rv2159c region and the cluster upstream of murE as far
as ftsQ were on separate mRNA transcripts, and that murE was
the first gene of the dcw operon in M. tuberculosis.
To screen for the promoter driving the dcw operon, the P1 and
P2 regions upstream of the putative operon were cloned in front of
lacZ in M. smegmatis. Blue colonies were observed for both regions,
indicating the presence of promoters. A b-galactosidase assay was
carried out for each, which further confirmed these results as
shown in figure 4C. This indicated that the promoter in the P1
region drives the transcription of the dcw operon with murE as a first
gene, while the promoter in the P2 region is responsible for driving
the upstream region of Rv2161c-Rv2160c-Rv2159c, where the
product of Rv2160c has been identified as a hypothetical protein
showing homology to the putative TetR-family transcriptional
regulator, which is currently under investigation. The P1 and P2
regions were screened for 210 and 235 sequences against the
previously identified promoters in mycobacteria species [33,34],
and were identified as showing consensus to those recognized by
a plethora of sigma factors present in M. tuberculosis, M. bovis and
M. paratuberculosis (Fig. 4A). The promoter (P1) for the dcw operon
was identified 123 nucleotides upstream of the GTG start site of
murE within the Rv2159c gene. This promoter has TGGTTG as
210 sequences and TCGACA as 235 sequences with a 12
nucleotides gap between them. Furthermore, the promoter in the
P2 region driving the Rv2161c-Rv2160c-Rv2159c was identified 32
nucleotides upstream of the transcription start site of Rv2161c with
CGTTAAACA as the 210 sequences and TTGACA as the 235
sequences and with a 20 nucleotides gap between them.
Figure 2. Determination of substrate specificities of Mur synthetases. Different (A) Nucleotides (B) Amino acids (C) Uridine sugars and (D)
divalent and monovalent cations (at 5 mM concentration) were tested to analyze their specificities for MurC, MurD and MurF synthetases. X-axis
represents different substrates used. Y-axis, in all the cases, represents the amount of Pi released in pmol/min.
doi:10.1371/journal.pone.0060143.g002
Figure 3. Estimation of optimal substrate concentration for
Mur synthetases. Inhibition curves obtained for MurC, MurD and
MurF synthetases with (A) ATP and (B) their respective uridine sugars. X-
axis represents substrate concentration used and Y-axis is the percent
inhibition calculated for each concentration.
doi:10.1371/journal.pone.0060143.g003
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Mur synthetases interact with cell division and other
regulatory proteins
We screened for interacting protein partners using the
mycobacterial protein fragment complementation (M-PFC)
method [35], which scores for resistance to TMP owing to the
regeneration of functional murine dihydrofolate reductase
(mDHFR) activity from its sub-domains encoded on separate
plasmids (pUAB100 and pUAB200). Significant growth was
observed at a concentration of 12.5 mg/mL of TMP for
interacting Mur synthetases and PknA/B proteins. The density
of growth for the interaction between MurC, D, E and F with
PknA was similar to the positive control, representing a strong
interaction. A comparatively weaker interaction was observed
between Mur synthetases and PknB (Fig. 5A). All M-PFC
interaction results were further quantified by determination of
the fluorescence intensity of viable cells using resazurin which
gives semi-quantitative estimates of the level of interaction
(Fig. 5B).
Interesting results were observed when screening Mur synthe-
tases for interacting partners amongst themselves as well as the
neighbouring cell division proteins in the genome. As shown in
figure 5, the cell division proteins FtsZ, FtsW, FtsQ, Wag31 and
Rv2147c (ortholog of SepF), were all found to interact with the
Mur synthetases. To confirm the specificity of these interactions,
the cell division proteins were also screened against the M.
tuberculosis Nat protein. No interaction was observed between Nat
and any of the cell division proteins. Furthermore, the absence of
interaction among the Mur synthetases acted as an additional
negative control supporting the validity of the M-PFC system for
interactions of these proteins. Proteins such as MurI, DapF, DdlA
and the product of Rv3818 (namH homologue), which are
responsible for providing substrates during PG biosynthesis, only
interacted with specific Mur synthetases (Fig. 5). Whilst MurI
(converts L-glutamate to D-glutamate) and DapF (transforms LL-
diaminopimelate to meso-diaminopimelate) were found to interact
with MurD and MurE, respectively, DdlA (ligates D-Ala and D-
Ala) and the NamH homologue (which converts the N-acetyl form
of UDP-sugar to the N-glycolyl form) interacted only with MurF
(Fig. 5). In addition the product of Rv2160c, which is present on
the operon immediately upstream of the dcw operon, also showed
interaction with all of the Mur synthetases.
Discussion
Structural and functional differences have been determined
between the cell wall PG of mycobacteria and other bacteria
[36,20,37], nevertheless, the biosynthesis of M. tuberculosis PG is
generally assumed to be similar to that of E. coli [38]. The cell wall
PG biosynthetic enzymes MurC, D, E and F in E. coli and M.
tuberculosis share limited sequence identity but have several highly
conserved regions that map primarily to the active site residues of
the enzymes.
Although we were able to produce sufficient amounts of MurE
[15] and MurC when over-expressed using the pET28b+ vector in
the E. coli system, attempts to over-express and purify MurD and
MurF using the same strategy were unsuccessful. However, using
P. putida as a host considerably improved both the quantity and
purity of MurF as well as MurC and MurE, preventing
contamination by the histidine-rich co-eluting E. coli proteins
SlyD (20 histidine residues) and ArnA (25 histidine residues). This
could be due to the fact that the homologues of these proteins have
less histidine residues in P. putida, and therefore they bind less
strongly to nickel resins, thus helping to overcome the limitations
of using E. coli as a standard heterologous system. The P. putida
system has also been successfully used earlier to purify the M.
tuberculosis HsaD protein [39], suggesting that the codon usage in
the P. putida strain is more favorable for overexpressing certain M.
tuberculosis proteins. MurD however, remained insoluble using the
above strategy. Furthermore, the co-expression of MurD with M.
Table 1. Kinetic parameters of MurC, MurD and MurF proteins for endogenous substrates.
MurC MurD MurE¤ MurF
KM
ATP (mM) 67.761.1 106.460.1 120 92.360.2
KM
UNAM/UMA/UMAG/UMT* (mM) 23.560.5 53.360.1 40 64.560.2
KM
L-Ala/D-Glu/mDAP/D-Ala-D-Ala (mM) 43.060.9 85.160.2 69 78.160.2
Vmax (mmol min21mg21) 1.260.1 0.860.1 1.2 0.960.01
kcat (sec
21) 1.060.01 0.860.2 1.2 1.460.5
kcat/KM
ATP (mM) 15.160.6 7.560.1 10 15.360.1
kcat/KM
UNAM/UMA/UMAG/UMT (sec21 mM21) 44.860.3 15.160.1 30 21.760.2
kcat/KM
L-Ala/D-Glu/mDAP/D-Ala-D-Ala (sec21 mM21) 23.960.23 9.460.12 17.4 18.160.3
kcat (E. coli) (sec
21) 15.4# 15.51 - 13.1¥
KM
L-Ser (mM) 99.760.5
KM
Gly (mM) 146.561.6
kcat
L-Ser (sec21) 1.260.01
kcat
Gly (sec21) 1.5360.1
kcat/KM
L-Ser (sec21 mM21) 12.560.02
kcat/KM
Gly (sec21 mM21) 10.4760.1
*UNAM: UDP-MurNAc; UMA: UDP-MurNAc-L-Ala; UMAG: UDP-MurNAc-L-Ala-D-Glu; UMT: UDP-MurNAc-L-Ala-c-D-Glu-m-DAP.
¤[15].
#[27].
1[67].
¥[32].
doi:10.1371/journal.pone.0060143.t001
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tuberculosis trigger factor (TigA) involved in the folding of nascent
proteins [40] or fusion of MurD with maltose binding protein (data
not shown), did not help in solubilizing the recombinant MurD
protein. M. tuberculosis MurD was finally obtained in its pure active
form after cleaving from an E. coli expressed fusion with E. coli
NusA (Table S2), which not only provided good solubilizing
properties, but also achieved a very high expression level, thus
making it a very good carrier for solubilizing large proteins.
Significant loss in specific activity was observed for all Mur
synthetases at temperatures above 40uC, with the enzymes
becoming increasingly unstable at higher temperatures. Further-
more, these proteins were highly sensitive to pH, showing optimal
activity at alkaline pH 8.0–8.5, as also seen earlier in the cases of
Figure 4. dcw operon analysis. (A) Representation of the M. tuberculosis genomic region (2408385–2424838), showing ORFs and gaps, and
highlighting regions upstream of the dcw operon screened for the presence of a promoter driving the operon. (B) cDNA analysis for identifying
boundaries of the dcw operon. (C) Promoter analysis by cloning into the promoter-less vector pYUB76 and b-galactosidase assay for confirmation of
promoter activity.
doi:10.1371/journal.pone.0060143.g004
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MurD [31] and MurE [15,41,42]. We further showed that
a concentration of UDP sugar higher than 0.2 mM led to
significant inhibition of the ligation activity. Similar inhibition was
also observed for substrates UDP-MurNAc-L-Ala and UDP-
MurNAc-L-Ala-c-D-Glu-m-DAP at concentrations higher than
0.1 mM in E. coli [43]. Therefore, conditions that may result in the
increase of intracellular levels of these substrates, may lead to
a decrease in the activity of Mur synthetases, thus presumably
regulating the rate at which cell wall PG synthesis occurs at
different physiological stages or under stress in M. tuberculosis.
Magnesium or manganese cations were essential for high levels of
Mur synthetase activities as assay mixtures which were either
devoid of any cation or contained 1–50 mM CaCl2, CdCl2,
CuCl2, FeCl2, NiCl2 and BaCl2 showed negligible activity. Indeed
K+ and NH4
+ gave slightly more activity, however Mg2+ is
proposed to be central to the activity of Mur synthases [44], and
there is no obvious trend from ionic radii or ligand geometry as to
which ions are capable of demonstrating activity. Furthermore, the
turnover numbers were found to be very similar for all M.
tuberculosis Mur synthetases under optimal conditions in vitro, but
lower than those found for E. coli Mur synthetases (Table 1).
It was interesting to observe that MurC synthetase from M.
tuberculosis showed activity not only with L-Ala and Gly as found
previously [13], but also with L-Ser as confirmed by HPLC and
LC-MS. Activity with L-Ser has been observed for the MurC
synthetase of E. coli [27], S. aureus [45] and Chlamydia trachomatis
[46]. The comparatively lower specificity for both L-Ser and Gly
may be a possible reason for L-Ala being the preferred substrate.
Interestingly, PG composition studied in E. coli showed neither L-
Ser nor Gly in the intracellular pool despite similar in vitro
specificity [47], suggesting that perhaps only L-Ala is successfully
incorporated into PG in vivo. Whether a downstream control for
composing the correct peptidoglycan precursor exists, where the
later Mur synthetases are unable to use UDP-MurNAc-Gly or
UDP-MurNAc-L-Ser or derivatives as substrates for ligating their
amino acids, remains to be experimentally confirmed for M.
tuberculosis.
The broad phylogenetic distribution and conservation of gene
order and gene content of the dcw cluster [48], together with the
association of genes involved in cell division and cell wall PG
biosynthesis, suggests interactions between genes. To identify the
genes co-transcribed with Mur synthetases, we carried out RT-
PCR in M. bovis BCG, which showed no intergenic amplification
between PE_PGRS38-Rv2161c, Rv2159c-murE and ftsQ-ftsZ. This
suggested that Rv2161c, murE and ftsZ are the first genes on
adjacent transcripts, and that the dcw operon spans from murE to
ftsQ. Multiple promoters have been identified for ftsZ earlier [49],
which further support our analysis. The hypothetical protein
Rv2160c, a putative tetR-family transcriptional regulator found
only in pathogenic mycobacteria and positioned on the adjacent
transcript, may be involved in the regulation of the genes of the
dcw cluster.
Phosphorylation by STPKs has recently emerged as a major
physiological mechanism for M. tuberculosis adaptation to host
stimuli [16,50,51]. PknA and PknB have been reported to regulate
cell division processes and cell wall biosynthesis through
phosphorylation of target proteins such as FtsZ [52], Wag31
[53], KasA and KasB [54] and GlmU [55]. In vitro studies have
also shown that MurC from Corynebaterium glutamicum [56] and
MurD from M. tuberculosis [57] interact with PknA, while PknB is
responsible for positioning of the PG biosynthesis protein PBPA in
M. tuberculosis [58], and that its deletion impacts the UDP-sugar
substrate concentrations and hence the cell wall synthesis [59].
Our studies showed that all four Mur synthetases interacted with
both PknA and PknB, which makes them likely substrates for their
phosphorylation by these STPKs. This suggested that the signal
transduction mediated by PknA and PknB are likely to act as
a switch for the PG biosynthesis pathway or effect phosphoryla-
tion-regulated protein-protein interactions during PG biosynthesis.
Though a similar signature phosphorylation motif (X-X-X-X-T-
Q-X-hydrophobic-hydrophobic) has been proposed for PknA and
PknB [53], these kinases differ in their substrate specificity at the
residues adjacent to the phosphoacceptor threonine [60]. This
may be a possible explanation towards the variation in the
intensity of interaction observed between PknA and PknB with
Mur synthetases.
Due to the lack of validation of Mur synthetases with inhibitors,
and more recently by interactions observed between MurF, MraY
and MurG in Caulobacter crescentus [61], there have been speculation
of the possible existence of a multi-enzyme complex between the
Mur synthetases [62] to explain the lack of activity of Mur
inhibitors in vivo. Our results however, for the first time indicate
that this may not be the case in M. tuberculosis, as none of the Mur
synthetases showed interaction with each other. Besides PknA/B,
other Mur synthetase-interacting partners in the PG biosynthesis
pathway were also identified. Specific interactions of MurI, DapF
and DdlA were observed only with the protein utilizing their
respective reaction product as a substrate, indicating a stringent
control of the products and substrates for Mur synthetases and
their neighbouring dependants. Furthermore, a recent report has
identified NamH as the protein responsible for glycolylation of
muramic acid [21] and Lipid II being its proposed substrate [20].
However, it has yet to be ascertained at which step of the pathway
this inter-conversion occurs, as well as the biological implications
or physiological functions of this structural difference in these PG
soluble precursors. In our study we observed that the namH
homologue (Rv3818) interacted exclusively with MurF, which
suggests that it may be acting before Lipid I synthesis, with the
glycolyl form possibly introduced into the last soluble, cytoplasmic
precursor (UDP-MurNAc-pentapeptide). This hypothesis howev-
er, has to be confirmed by determining the activities of Mur
synthetases in the presence of the glycolylated UDP-sugar
substrates.
As cell division and PG biosynthesis genes share the dcw cluster,
and that the PG biosynthetic protein PBP3 has been reported
earlier to interact with both FtsW and FtsZ forming a trimeric
complex in mycobacteria [63], it was reasoned that an interaction
between the Mur synthetases and cell division proteins could exist.
FtsZ, FtsW and FtsQ constitute the core of bacterial division
machinery along with other cell division proteins [64]; Wag31,
a homologue of DivIVA, regulates polar cell wall synthesis [65],
and the Bacillus homologue of Rv2147c, has been reported to play
a role in septum development [66]. Our investigation showed that
these cell division proteins, which are in close proximity to the
Mur synthetases on the dcw cluster, interacted with all four of the
Mur synthetases. This data reveals that there is interplay between
these cell division proteins and the Mur synthetases, which could
Figure 5. Protein-protein interaction studies of M. tuberculosis Mur synthetases. (A) Interaction using an M-PFC where growth on TMP
plates at 12.5 mg/mL concentration indicated a positive protein-protein interaction, (B) Quantitation of M-PFC interactions by the resazurin assay and
(C) representation of final interaction results. Each interaction, by both methods, was assayed in triplicate.
doi:10.1371/journal.pone.0060143.g005
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be a way to tightly control the delicate balance between septation
and PG elongation during daughter cell formation.
In this study, we have characterised the dcw operon in M.
tuberculosis and gained further insights into the function and
regulatory network of Mur synthetases. The results from our study
are a step towards inhibiting this network with new target-specific
small-molecule inhibitors, which would be potentially effective
drugs against TB.
Supporting Information
Figure S1 Optimisation of the physical conditions for
Mur synthetases. Effect of increase in temperature (Ai) and
stability of Mur synthetases at room temperature (Aii) over
10 days. Effect of different pH and buffers (B) on the activity of
MurC (i), MurD (ii) and MurF (iii). X-axis represents days,
different temperatures, or buffers used. Y-axis, in all the cases,
represents the amount of Pi released in pmol/min.
(TIF)
Figure S2 Confirmation of formation of UDP-MurNAc-
L-Ala, UDP-MurNAc-L-Ser and UDP-MurNAc-Gly by
MurC of M. tuberculosis. Reverse-phase C-18 HPLC
chromatograms at 268 nm (i) and negative-mode mass spectrom-
etry (ii) of the product reaction with (A) L-alanine (B) L-serine and
(C) glycine. The lines in black represent the chromatogram before
addition of the enzyme and the lines in red represent the
chromatogram after addition and incubation for 1 hr. The mass
spectra were recorded for the major peaks (in the red line) of the
products of the reaction with L-Ala, L-Ser and Gly.
(TIF)
Table S1 Constructs prepared in this study. * Restriction
sites are underlined.
(DOCX)
Table S2 Details of purified Mur synthetases.
(DOCX)
Table S3 Primers for RT-PCR.
(DOCX)
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